Nasdaq:US$14.59 (-0.41) | HKEX:HK$22.30 (-0.80) | AIM:£2.41 (-0.04)
News & Presentations
Previous Article   |   Next Article
Presentations, Scientific Publications | 14 Oct 2012

ISSX 2012: Pharmacokinetic/Pharmacodynamic Modeling of Epitinib to Evaluate the Anti-cancer Effect on A431 Tumor Xenograft in Nude Mice